John Powers

John Powers and Cheryl Coon discuss framing COA endpoints, emphasizing the importance of protocol clarity, treatment benefits, evidence, and patient-centric analysis. They also explore the complexities of specifying endpoints, the balance between specificity and broadness, and the innovative approach to developing outcome measures in clinical trials.

Patient-centered drug development expert Sonya Eremenco and clinical research specialist John Powers discuss the importance of putting patients at the heart of COA approaches in clinical research, from concept to endpoint positioning. They explore the significance of aligning COA strategy with patient priorities, measuring disease attributes, and consulting patients early to determine key measures for improved participation and relevant metrics.